Pharmacogenomics Journals

The reader is also referred to a number of journals specifically devoted to this field of research Pharmacogenetics published by Lippincott Williams and Wilkins Pharmacogenomics published by Ashley Publications Ltd. American Journal of Pharmacogenomics published by ADIS international The Pharmacogenomics Journal published by Nature Publishing group... [Pg.951]

Wadelius, M. and Pirmohamed, M. (2007). Pharmacogenetics of warfarin current status and future challenges. Pharmacogenomics Journal 7, 99-111. [Pg.372]

Ingelman-Sundberg, M. (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics Journal, 5 (1), 6-13. [Pg.235]

Pullarkat, S. T., Stoehlmacher, J., Ghaderi, V., et al. (2001) Thymidylate synthase gene polymorphism determines response and toxicity of 5-EU chemotherapy. Pharmacogenomics Journal. 1, 65-70. [Pg.433]

Pereira, A., McLaren, A., Bell, W.R., Copolov, D. and Dean, B. (2003) Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. The Pharmacogenomics Journal, 3, 227-234. [Pg.435]

Simon R, Wang S J. Use of genomie signatures in therapeuties development. The Pharmacogenomics Journal 2006 6 166-173. [Pg.338]

Wertz, D. C. 2003. Ethical, Social and Legal Issues in Pharmacogenomics. The Pharmacogenomics Journal 3 194-196. [Pg.105]

Butcher NJ, Boukouvala S, Sim E, Minchin RF (2002) Pharmacogenetics of the arylamine N-acetyltransferases. The Pharmacogenomics Journal 2 30-42... [Pg.733]

Guillemette C (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. The Pharmacogenomics Journal 3 136-158... [Pg.734]

Journal of Proteome Research (ACS Pubs) Molecular Genetics and Genomics (Springer) Pharmacogenomics Journal (Nature Publishing Group)... [Pg.1426]

Chen, X. and Sullivan, P. F. Single nucleotide polymorphism genotyping Biochemistry, protocol, cost and throughput. Pharmacogenomics Journal 3, 77-96 (2003). [Pg.412]

Rioux, P. P. 2000. Clinical Trials in Pharmacogenetics and Pharmacogenomics Methods and Applications. American Journal of Health-System Pharmacy S7 887-901. [Pg.105]

New England Journal of Medicine 338 1128-1137 Pirmohamed M 2001 Pharmacogenetics and pharmacogenomics. British Journal of Clinical Pharmacology 54 345-357 Report 1997 Medication for older people. Royal College of Physicians, London Rolf S, Harper N J N 1995 Ability of hospital doctors to calculate drug doses. British Medical Journal 310 1173... [Pg.133]

American Journal of Pharmacogenomics (Adis) Bioinformatics (Oxford)... [Pg.1426]

B. Robson and R. Mushlin. 2003. Clinical and pharmacogenomic data mining 1. The generalized theory of expected information and application to the development of tools. Journal of Proteome Research 2 283-301. [Pg.572]

B. Robson. 2005. Clinical and pharmacogenomic data mining 3. Zeta theory as a general tactic for clinical bioinformatics. Journal of Proteome Research 4(2) 445 55. [Pg.572]

B. Robson. 2008. Clinical and pharmacogenomic data mining 4. The FANO program and command set as an example of tools for biomedical discovery and evidence based medicine. Journal of Proteome Research 7(9)3922-3947. [Pg.572]

Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., Sadee, W. (2001 Nov 14). Potential role of pharmacogenomics in reducing adverse drug reactions A systematic review. JAMA The Journal of the American Medical Association, 25d(18), 2270—2279. [Pg.348]

In the context of employing pharmacogenomic biomarkers in the prediction of severe adverse drug reactions, Ingelman-Sundberg commented in an editorial piece in the New England Journal of Medicine as follows (2008, p. 637) ... [Pg.309]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...